6-Amino-4-methoxy-2- (β-D-ribofuranosyl) -2H-pyrazolo[3,4-d]pyrimidine

This purine nucleoside analog, 6-amino-4-methoxy-2- (β-D-ribofuranosyl) -2H-pyrazolo[3,4-d]pyrimidine, demonstrates broad antitumor activity, notably against indolent lymphoid cancers. Its primary mechanisms involve inhibiting DNA synthesis and triggering apoptosis, as shown in various in vitro and in vivo oncology research models.